Code | 3190A | ||||||||||
MA number | 14/0492/12-S | ||||||||||
Product Form: | tbl mnd 28(2x14)x5 mg (blis.Al/Al) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | National | ||||||||||
MAH, country: | BELUPO, s.r.o., Slovakia | ||||||||||
Therapeutic Class: | 14 - BRONCHODILATANTIA, ANTIASTHMATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | blister Al/Al | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 30.11.2012 |
Pediatric posology: | Yes |
PIL: | PIL_Belokast 5 mg_09_2022.pdf |
SPC: | SPC_Belokast 5 mg_09_2022.pdf |
Safety feature | Yes |
Data update: | 06.03.2018 |